Bio

Lyn Denend is a lecturer with the Stanford School of Medicine and the director for academic programs at Stanford Biodesign. In her Biodesign role, she is responsible for developing curriculum, teaching in multiple courses and programs, and helping Stanford Biodesign strengthen its educational content. Lyn is also the principal writer for both editions of the Biodesign textbook. Previously, Lyn worked at the Stanford Graduate School of Business as the staff director for the Program in Healthcare Innovation. Additionally, she was a research associate with the GSB’s case writing office, where she authored a variety of research papers and created multi-media teaching materials. Prior to joining the Stanford community, Lyn was a management consultant. She has an MBA from Duke's Fuqua School of Business and a BA in communications from the University of California, Santa Barbara.

Current Role at Stanford

Director for Academic Programs, Stanford Biodesign
Lecturer, Stanford Medicine

Honors & Awards

  • Inspiring Change Leadership Award, Stanford Medicine (May 13, 2015)

Education & Certifications

  • BA, University of California, Santa Barbara, Communications (1989)
  • MBA, Fuqua School of Business, Duke University, Business (1996)

Contact

  • Work
    denend@stanford.edu
    University - Staff Department: School of Medicine - MDRP'S - Biodesign Program Position: Academic Prog Prof Mgr
    • Stanford Biodesign Program
    • James H. Clark Center
    • 318 Campus Drive, E128
    • Stanford,  California  94305 
    University - Other Teaching/Research Department: Med/Primary Care and Population Health Position: Lecturer

Additional Info

  • Mail Code: 5428

Links

Work Experience

  • Senior Manager, Cap Gemini Ernst & Young

    Location

    San Jose, CA

All Publications

  • Needs-Based Innovation in Interventional Radiology: The Biodesign Process TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY Steinberger, J. D., Denend, L., Azagury, D. E., Brinton, T. J., Makower, J., Yock, P. G. 2017; 20 (2): 84–89

    Abstract

    There are many possible mechanisms for innovation and bringing new technology into the marketplace. The Stanford Biodesign innovation process is based in a deep understanding of clinical unmet needs as the basis for focused ideation and development. By identifying and vetting a compelling unmet need, the aspiring innovator can "derisk" a project and maximize chances for successful development in an increasingly challenging regulatory and economic environment. As a specialty founded by tinkerers, with a history of disruptive innovation that has yielded countless new ways of delivering care with minimal invasiveness, lower morbidity, and lower cost, interventional radiologists are uniquely well positioned to identify unmet needs and develop novel solutions free of dogmatic convention.

    View details for PubMedID 28673651

  • The impact of postgraduate health technology innovation training: Outcomes of the Stanford Biodesign Fellowship. Annals of Biomedical Engineering Wall, J., Hellman, E., Denend, L., Rait, D., Venook, R., Azagury, D., Yock, P., Brinton, T. 2016

    View details for DOI 10.1007/s10439-016-1777-1

  • Biodesign: The Process of Innovating Medical Technologies Denend, L. edited by Yock, P., Zenios, S., Makower, J., Brinton, T., Kumar, U., Watkins, J. Cambridge University Press. 2015
  • Sustaining Pressure Ulcer Best Practices in a High-Volume Cardiac Care Environment How one hospital reduced the incidence of hospital-acquired pressure ulcers to zero AMERICAN JOURNAL OF NURSING Paul, R., McCutcheon, S. P., Zenios, S. A., Tregarthen, J. P., Denend, L. T. 2014; 114 (8): 34-44

    View details for Web of Science ID 000340557800018

  • Meeting the Challenges of Global Health; pages 37-41 Stanford Social Innovation Review Denend, L., Lockwood, A., Barry, M., Zenios, S. 2014; 12 (Number 2)